Skip to content

Clinical trials

Completed Phase 2 Acute Coronary Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 2 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20064
20076
20084
20094
20102
20112
20122
20131
20141
20153
20162
20171
20182
20192
20202
20212
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Cerenis Therapeutics, SA2
Damanhour University2
Johns Hopkins University2
University of Alabama at Birmingham2
ARCA Biopharma, Inc.1
Amosov National Institute of Cardiovascular Surgery1
Anthera Pharmaceuticals1
Astellas Pharma Europe B.V.1
Azienda USL Toscana Centro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome46
Myocardial Infarction7
Angina, Unstable6
Coronary Artery Disease6
Coronary Disease4
ST Elevation Myocardial Infarction4
Atherosclerosis3
Heart Diseases3
Myocardial Ischemia3
Acute Kidney Injury2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.